文献速递妇科

脱垂修复术后减少阿片类药物处方的随机对照非劣效性试验

A randomized controlled noninferiority trial of reduced vs routine opioid prescription after prolapse repair.
PubMed 文献 · Am J Obstet Gynecol · 2020-03-19

该单中心、非盲、两臂随机对照非劣效性试验纳入118例接受脱垂修复术并计划过夜住院的女性,比较常规处方(28片5mg羟考酮)与减少处方(5片)的患者术后疼痛控制满意度。结果显示两组满意度均为93%,差异<15%,达到非劣效性;减少处方组更常需要额外阿片类药物处方(15% vs 2%,P=.01),但两组均存在大量剩余药片。

要点

  • 脱垂修复术后减少阿片类药物处方(5片)在疼痛控制满意度上非劣效于常规处方(28片)。
  • 减少处方组需要额外阿片类药物处方的比例更高(15% vs 2%,P=.01)。
  • 两组均存在大量未使用的阿片类药物片剂,常规组中位数剩余26片。

核心结论

  • 脱垂修复术后减少阿片类药物处方(5片)的患者疼痛控制满意度非劣效于常规处方(28片)。
  • 两组均存在大量剩余阿片类药物片剂,建议术后处方5-10片并考虑推广至其他妇科手术。

研究设计与样本

  • 单中心、非盲、两臂随机对照非劣效性试验,纳入118例接受脱垂修复术且计划过夜住院的女性。
  • 随机分为常规处方组(28片5mg羟考酮)和减少处方组(5片),所有患者出院时均接受多模式镇痛。
  • 主要结局为术后6周常规随访时调查的患者满意度,非劣效性样本量计算为每组59例,共118例。

主要发现

  • 116例有主要结局数据,平均年龄62±10.4岁,最常见手术为子宫切除术加自体组织修复(n=71;60%)。
  • 减少处方组需要额外阿片类药物处方的比例高于常规组(15% vs 2%;P=.01)。
  • 常规组阿片类药物使用量中位数为3片(IQR 0-14),减少组为1片(IQR 0-3);常规组剩余药片中位数为26片(IQR 15-28),减少组为4片(IQR 2-5)。

关键数值与推荐

  • 常规处方为28片5mg羟考酮,减少处方为5片。
  • 非劣效性界值为差异<15%,两组满意度均为93%(P=.005)。
  • 作者建议脱垂修复术后处方5-10片阿片类药物。

临床怎么用

  • 妇科医生在脱垂修复术后可考虑将阿片类药物处方量减少至5-10片,而不影响患者疼痛控制满意度。
  • 减少处方可能增加额外处方需求,需做好术后疼痛管理和随访。
  • 该 findings 可考虑应用于其他妇科手术的术后处方。

局限性

  • 单中心、非盲设计可能引入偏倚。
  • 样本以白人、绝经后、不吸烟女性为主,外推性受限。
  • 排除慢性疼痛、术前阿片类药物使用及疼痛灾难化评分≥30的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Given the accelerating opioid crisis in the United States and evidence that patients use fewer opioid tablets than prescribed, surgeons may choose to decrease prescribed quantities. The effect this may have on patient satisfaction with pain control after hospital discharge is unknown. OBJECTIVE: The primary objective of this study was to compare patient satisfaction with postoperative pain control between patients receiving a routine or reduced quantity opioid prescription after prolapse repair. Secondary objectives included a comparison of opioid-related side-effects, the number of opioid tablets used, and the number of excess tablets prescribed between these groups. STUDY DESIGN: This was a single-center, unmasked, 2-arm, randomized controlled noninferiority trial of women who underwent a prolapse repair with a planned overnight hospitalization. Patients were assigned randomly to 1 of 2 study arms: routine (28 tablets of oxycodone 5 mg) or reduced (5 tablets) prescription of opioid tablets. Patients were eligible if they were at least 18 years of age and undergoing a prolapse repair with an anticipated overnight hospital stay. Exclusion criteria included a history of chronic pain, preoperative opioid use, intolerance to study medication, or a score of ≥30 on the Pain Catastrophizing Scale. In addition to their opioid prescription, all patients received multimodal pain medications at discharge. Patients were asked to complete 6 weeks of diaries to record pain and medication use. The primary outcome (patient satisfaction) was collected as part of a postoperative survey completed at patients' routine postoperative visit 6 weeks after surgery. The sample size for noninferiority was calculated at 59 patients per group for a total of 118 patients. RESULTS: One hundred eighteen patients were assigned randomly; the primary outcome was available for 116. The majority of patients were white, postmenopausal, and nonsmokers; the mean age was 62±10.4 years. The most common surgery was a hysterectomy with native tissue repair (n=71; 60%). One hundred ten patients (93%) were satisfied with postoperative pain control. Statistical analysis constructed for noninferiority showed that the difference between the groups was <15% (93% vs 93%; P=.005). Subjects in the reduced arm reported requiring an additional opioid prescription more frequently than in the routine arm (15% vs 2%; P=.01). Patients in the routine arm used more opioid tablets than the reduced arm (median, 3 [interquartile range, 0-14] vs 1 [interquartile range, 0-3]), but overall opioid utilization was low. As such, patients in the routine arm had significantly more unused opioid tablets (median, 26 [interquartile range, 15-28] vs 4 [interquartile range, 2-5]). CONCLUSION: Patient satisfaction with pain control was noninferior in patients who received a reduced quantity of opioid tablets after prolapse repair compared with those who received a routine prescription. A large quantity of excess opioid tablets was seen in both groups. Surgeons should consider prescribing 5-10 opioid tablets after prolapse repair surgery and consider applying these findings to postoperative prescribing after other gynecologic procedures.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Davidson ERW, Paraiso MFR, Walters MD, et al. A randomized controlled noninferiority trial of reduced vs routine opioid prescription after prolapse repair. Am J Obstet Gynecol. 2020. PMID: 32199926. doi:10.1016/j.ajog.2020.03.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。